Find More Contacts for Pernix Therapeutics
Protected Content
General Counsel, Senior VP
Executive Management
1 email found
View contacts for Pernix Therapeutics to access new leads and connect with decision-makers.
View All Contacts
  • Phone Number 800-793-2145

Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products primarily for the pediatric market. The Company’s pediatric products, designed to improve the health and well-being of children, are focused in the specific areas of allergy, upper

respiratory, including nasal, chest congestion and cough, antibiotics and dermatology, including head lice, and contact dermatitis. The Company promotes its products through a sales and marketing organization with approximately 55 sales representatives, primarily in highly populated states, targeting pediatric and high-prescribing physicians that are in the top decile of physicians that prescribe its products. The Company’s current operating plan focuses on maximizing sales of its existing product portfolio. In addition, Pernix plans to accelerate growth by launching new products, line extensions, and new formulations and by acquiring and licensing approved products.

Lists Featuring This Company

Athyrium Capital Management LP Portfolio Companies
36 Number of Organizations • $18.7B Total Funding Amount • 247 Number of Investors
Greater Houston Area Companies that Exited
1,799 Number of Organizations • $95.9B Total Funding Amount • 617 Number of Investors
Southern US Companies that Exited (Top 10K)
9,911 Number of Organizations • $607.6B Total Funding Amount • 11,306 Number of Investors
Companies that Went Public in 2003
1,291 Number of Organizations • $108.6B Total Funding Amount • 526 Number of Investors
Pernix Therapeutics was acquired by Currax Pharmaceuticals on May 1, 2019.

Frequently Asked Questions

Where is Pernix Therapeutics's headquarters? Pernix Therapeutics is located in Houston, Texas, United States.Who invested in Pernix Therapeutics? Pernix Therapeutics is funded by Athyrium Capital Management LP.How much funding has Pernix Therapeutics raised to date? Pernix Therapeutics has raised .When was the last funding round for Pernix Therapeutics? Pernix Therapeutics closed its last funding round on Feb 6, 2014 from a Post-IPO Debt round.Who are Pernix Therapeutics's competitors? Alternatives and possible competitors to Pernix Therapeutics may include Lannett CompanyRecro Pharma, and BionPharma.